Calcium magnesium supplement UK: what the sleep evidence says

Both calcium and magnesium have well-characterised roles in neurological function, and low intakes of either are common in UK adults. The combined supplementation literature is thinner than the single-mineral literature, but a Cochrane-adjacent review of mineral supplementation in ageing populations found meaningful associations between magnesium status and sleep architecture. The honest answer is that the evidence is promising but not settled, and form and dose matter enormously.

Calcium and magnesium are not interchangeable sleep aids; they work through distinct neurological pathways, and the evidence for each is at a different stage of maturity.

From this read

What the evidence actually shows

I want to be straight with you about where the evidence sits. There is a reasonable body of research on magnesium and sleep in isolation. The calcium-specific sleep literature is smaller. And the combined calcium-magnesium-for-sleep literature is thinner still. So when you see a product marketed as a "sleep mineral complex, " the claim is often extrapolated from the individual mineral research rather than from studies on the combination itself.

Welham et al. (2024) published a review of mineral supplementation in ageing populations that covers both calcium and magnesium. Their assessment is that magnesium has the stronger evidence base for sleep-relevant outcomes, particularly in older adults where absorption declines and dietary intake is frequently inadequate. Calcium's role is characterised as more indirect, operating through melatonin synthesis pathways rather than direct sedative mechanisms.

Beyer et al. (2006) conducted a Cochrane review of combined calcium, magnesium, and potassium supplementation for primary hypertension management. The sleep outcomes were not the primary endpoint, but the cardiovascular data is worth understanding because autonomic nervous system tone at night is closely coupled to sleep quality. The review found a modest but consistent reduction in systolic blood pressure of approximately 3 mmHg with combined mineral supplementation, which has downstream relevance for sleep onset and nocturnal arousal.

For a broader picture of how I approach the evidence on individual sleep-relevant ingredients, see my piece on natural sleep supplement UK options, which covers the wider field.

Sibal et al. (2026) reviewed micronutrient monitoring in the context of metabolic interventions and noted that magnesium and calcium are among the minerals most frequently depleted in adults with poor dietary variety, a population that disproportionately reports sleep difficulties. The association is observational, not causal, and I would overstate it to claim otherwise.

The biology: what calcium and magnesium are actually doing at night

These two minerals are not doing the same thing. They share some metabolic pathways, but their sleep-relevant mechanisms are distinct enough that it is worth separating them.

Magnesium's neurological role

Magnesium is an NMDA (N-methyl-D-aspartate) receptor antagonist. At physiological concentrations, it blocks the NMDA receptor channel in a voltage-dependent manner, reducing excitatory glutamate signalling in the central nervous system. In practical terms, this means that adequate magnesium status is associated with lower cortical excitability, which is one of the prerequisites for sleep onset. When magnesium levels are low, the NMDA receptor block is weaker, and the nervous system remains in a more aroused state.

Magnesium also plays a role in regulating the hypothalamic-pituitary-adrenal axis. Low magnesium may allow cortisol to remain elevated longer into the evening, which directly opposes the melatonin rise that initiates sleep. This is a plausible mechanism, though the human data linking magnesium supplementation to measurable cortisol reduction at night is limited.

Calcium's role in melatonin synthesis

Calcium's sleep connection is less direct but still biologically plausible. Melatonin synthesis in the pineal gland requires tryptophan hydroxylase activity, and calcium ions are involved in the enzymatic regulation of this pathway. Serum calcium follows a circadian rhythm in healthy adults, with concentrations rising at night, and some researchers have proposed that this nocturnal rise facilitates the melatonin surge that drives sleep onset.

Kiam et al. (2022) conducted a UK national audit of chronic hypoparathyroidism, a condition characterised by chronically low serum calcium. Patients in that cohort reported significantly disrupted sleep as one of the most common quality-of-life complaints, which is consistent with the hypothesis that calcium status influences sleep architecture. The caveat is that hypoparathyroidism is a clinical condition, not dietary insufficiency, so the extrapolation to healthy adults taking a supplement requires caution.

The two minerals also interact metabolically. Calcium and magnesium compete for the same intestinal transporter proteins, which is why the ratio in a supplement matters. Very high calcium relative to magnesium can reduce magnesium absorption, and vice versa. A 2:1 calcium-to-magnesium ratio is the most commonly cited target in the clinical literature, though the human data supporting this specific ratio for sleep outcomes is limited.

Dosing: what the clinical evidence actually supports

The UK Reference Nutrient Intake for magnesium is 300 mg per day for adult men and 270 mg per day for adult women. For calcium, it is 700 mg per day for adults. These are dietary targets, not supplementation targets, and the gap between what UK adults actually consume and what they need varies considerably by age and dietary pattern.

In the hypertension review by Beyer et al. (2006), the trials included in the analysis used magnesium doses ranging from 240 mg to 960 mg per day and calcium doses from 400 mg to 2, 000 mg per day. The heterogeneity in those ranges reflects the lack of consensus on an optimal supplementation dose rather than any deliberate design. The modest blood pressure effect seen in the review was not clearly dose-dependent within that range.

Welham et al. (2024) suggest that for older adults, supplementing 200 to 400 mg of elemental magnesium daily is a reasonable target based on current evidence, with the lower end appropriate for those already achieving reasonable dietary intake. For calcium, they note that supplementation above 500 to 600 mg per day in older adults may not confer additional benefit for bone outcomes and could have cardiovascular implications, so more is not straightforwardly better.

For magnesium specifically in the context of sleep, the research I find most credible uses doses in the 300 to 500 mg elemental magnesium range, taken in the evening. I cover the form question in more detail in my piece on magnesium glycinate supplement UK sleep evidence, but the short version is that glycinate and citrate forms outperform oxide in terms of absorption and gastrointestinal tolerance.

The KōJō Daily Formula takes a different structural approach to sleep support. Rather than relying on calcium or magnesium as the primary mechanism, it includes 2, 000 mg of glycine in crystalline powder form. Glycine is an amino acid with some early-stage human research suggesting it may support sleep quality, though large-scale trials are still limited and I would not overstate the current evidence base for it.

Who is most likely to benefit from a calcium magnesium supplement in the UK

Not everyone taking a calcium magnesium supplement will notice the same response, and that is not a hedge, it is a straightforward reflection of the biology. The people most likely to see a meaningful effect are those who start with genuinely low intakes of one or both minerals.

Koller et al. (2024) conducted a systematic review of micronutrient status in children and adolescents on vegan diets and found that calcium and magnesium were among the minerals most consistently below recommended intakes in that population. The same pattern appears in adult vegans, in people with inflammatory bowel conditions, and in older adults where intestinal absorption declines with age.

Nightingale (1995) documented significant magnesium and calcium losses in patients with short bowel syndrome, a condition that dramatically reduces mineral absorption. While this is a clinical extreme, it illustrates that gut health and absorptive capacity are the real determinants of mineral status, not just dietary intake.

Blanchard et al. (2017) reviewed Gitelman syndrome, a genetic condition causing chronic magnesium and potassium wasting through the kidney. Patients in that cohort consistently reported fatigue and sleep disturbance as primary symptoms. Again, this is a clinical population, not healthy adults, but the mechanistic signal is consistent with the broader magnesium-sleep hypothesis.

In practical terms, the groups most likely to benefit from supplementation in a UK context include adults over 60, people following plant-based diets without careful planning, those using proton pump inhibitors (which reduce magnesium absorption), and people with chronically high stress loads that may accelerate urinary magnesium excretion.

The form problem: why most UK calcium magnesium supplements underdeliver

This is where I get frustrated with the UK supplement market. The majority of calcium magnesium tablets sold in UK pharmacies and supermarkets use calcium carbonate and magnesium oxide. Both are cheap. Both have poor bioavailability relative to other forms. Magnesium oxide has an absorption rate of roughly 4% in some studies, compared to 50 to 60% for magnesium glycinate. Calcium carbonate requires stomach acid for dissolution, which means it is poorly absorbed in people with low gastric acid, a common situation in older adults and those on acid-suppressing medications.

Chadwick et al. (2020) examined sample contamination issues in laboratory calcium measurements, which is a methodological paper rather than a supplementation study, but it underlines how sensitive calcium measurement is to handling and form. The broader point is that not all calcium is equivalent in how the body processes it, and the same logic applies to supplemental forms.

Mantle et al. (2005) discussed nutritional supplement strategies for connective tissue conditions and noted that mineral bioavailability is a consistently underappreciated variable in supplement design. The form of the mineral, its co-factors, and the presence of competing minerals in the same product all influence how much actually reaches systemic circulation.

If you are buying a calcium magnesium supplement in the UK specifically for sleep support, look for magnesium glycinate or magnesium citrate rather than magnesium oxide. For calcium, calcium citrate is better absorbed than calcium carbonate, particularly if you are not taking it with food. These distinctions are not marketing; they are pharmacokinetics.

Calcium, magnesium, and cardiovascular health: the sleep connection

Sleep quality and cardiovascular health are bidirectionally linked. Poor sleep raises blood pressure and heart rate variability in the short term. Chronically elevated blood pressure disrupts sleep architecture. So when Tangvoraphonkchai et al. (2019) reviewed magnesium's role in cardiovascular disease and found that low serum magnesium is associated with increased risk of hypertension, atrial fibrillation, and endothelial dysfunction, the sleep implications are not incidental.

The same review noted that magnesium may reduce arterial stiffness, which is a marker of cardiovascular risk that also correlates with nocturnal blood pressure dipping. Adequate nocturnal blood pressure dipping (typically a 10 to 20% reduction in blood pressure during sleep) is associated with better sleep quality and lower cardiovascular event rates. Whether magnesium supplementation restores impaired nocturnal dipping in humans with low magnesium status is a question the current evidence does not fully answer.

Beyer et al. (2006) found that combined calcium and magnesium supplementation produced a mean systolic blood pressure reduction of approximately 3 mmHg in hypertensive adults. That is a modest effect at the population level but clinically meaningful for an individual who also has disrupted sleep secondary to elevated nocturnal blood pressure.

I would not position a calcium magnesium supplement as a cardiovascular intervention. But the cardiovascular and sleep data point in the same mechanistic direction, and that coherence is worth noting when you are evaluating whether the combination makes sense for you.

Muscle cramps, sleep disruption, and the mineral connection

Nocturnal leg cramps are a significant and underappreciated cause of sleep disruption in UK adults, particularly those over 50. The mineral connection here is direct. Both calcium and magnesium are required for normal muscle contraction and relaxation. Low levels of either can increase neuromuscular excitability and the likelihood of spontaneous cramping.

Young (2018) reviewed the evidence on leg cramps and found that while the data on magnesium supplementation for non-pregnancy-related nocturnal cramps is mixed, the mechanistic rationale is sound and the safety profile of supplementation at standard doses is good. A separate review by Young (2016) reached similar conclusions: magnesium supplementation may reduce cramp frequency in some populations, but the effect size is modest and the evidence is not definitive.

The practical implication is that if nocturnal cramps are part of what is disrupting your sleep, a calcium magnesium supplement is a reasonable, low-risk option to try, with the caveat that the evidence for it is suggestive rather than conclusive. If cramps are severe, frequent, or accompanied by other symptoms, that is a conversation to have with a clinician rather than a supplement question.

Welham et al. (2024) note that in ageing populations, the threshold for mineral deficiency at which clinical symptoms appear is lower than previously thought, meaning that some people experience muscle and sleep symptoms at serum levels that would be classified as "normal" on standard blood tests. This is a nuance that gets lost in the binary deficient/not-deficient framing of most clinical assessments.

Frequently asked questions

My honest take

I spent a long time looking at this category before deciding what KōJō would and would not include. The calcium magnesium combination has a genuine biological rationale for sleep support, and I do not think it is snake oil. But I also think the UK market is full of products that use cheap forms at doses that are unlikely to move the needle, then sell them on the back of loosely extrapolated evidence.

The magnesium data for sleep is the more compelling half of this equation. The human trials are small and the effect sizes are modest, but the mechanistic coherence is there, and the safety profile at standard doses is good. The calcium data for sleep is more speculative. The hypoparathyroidism research and the circadian calcium rhythm data are interesting, but the jump from clinical calcium deficiency to "take a calcium supplement and sleep better" is a long one.

What I find genuinely useful in the research is the ageing angle. Welham et al. (2024) make a credible case that mineral supplementation in older adults is one of the more evidence-grounded interventions available, precisely because absorption declines and dietary intake often falls with age. If you are in that category, a well-formulated calcium magnesium supplement is probably worth trying.

For a broader view of how I evaluate the evidence on sleep-relevant ingredients, my piece on KōJō: what the evidence actually shows covers the methodology I use when deciding what goes into a formula and what stays out.

The KōJō formula does not currently include calcium or magnesium as standalone minerals. The sleep-relevant ingredients I chose to include are glycine (2, 000 mg) and taurine (2, 000 mg), both of which have early-stage human research suggesting they may support aspects of sleep quality, though large-scale trials for both are still limited and I would not overstate the current evidence base. The decision to prioritise those over calcium and magnesium was deliberate, based on the specificity of the mechanism and the forms available, not because calcium and magnesium are not worth supplementing.

If you are looking at a combined calcium magnesium product, my practical advice is simple: check the form, check the dose of elemental mineral (not the salt weight), and take it in the evening. And if you have been sleeping poorly for an extended period, that is worth investigating beyond the supplement aisle.

This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.